Net Worth Advisory Group Invests $932,000 in The Cooper Companies, Inc. (NASDAQ:COO)

Net Worth Advisory Group purchased a new stake in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 8,445 shares of the medical device company's stock, valued at approximately $932,000.

Several other large investors have also modified their holdings of the business. American International Group Inc. boosted its position in Cooper Companies by 1.0% during the fourth quarter. American International Group Inc. now owns 13,229 shares of the medical device company's stock worth $5,006,000 after acquiring an additional 137 shares during the last quarter. Wellington Management Group LLP boosted its position in Cooper Companies by 34.8% during the fourth quarter. Wellington Management Group LLP now owns 8,189 shares of the medical device company's stock worth $3,099,000 after acquiring an additional 2,116 shares during the last quarter. Nomura Holdings Inc. acquired a new stake in Cooper Companies during the fourth quarter worth approximately $373,000. CWM LLC raised its stake in Cooper Companies by 365.7% during the first quarter. CWM LLC now owns 3,637 shares of the medical device company's stock worth $369,000 after purchasing an additional 2,856 shares during the period. Finally, GAMMA Investing LLC raised its stake in Cooper Companies by 388.6% during the first quarter. GAMMA Investing LLC now owns 1,930 shares of the medical device company's stock worth $196,000 after purchasing an additional 1,535 shares during the period. 24.39% of the stock is currently owned by institutional investors and hedge funds.

Insider Activity

In related news, CEO Albert G. White III sold 114,992 shares of Cooper Companies stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total value of $12,710,065.76. Following the sale, the chief executive officer now directly owns 165,273 shares in the company, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. In other Cooper Companies news, CFO Brian G. Andrews sold 24,788 shares of the business's stock in a transaction dated Thursday, September 5th. The shares were sold at an average price of $105.90, for a total transaction of $2,625,049.20. Following the sale, the chief financial officer now directly owns 6,614 shares in the company, valued at approximately $700,422.60. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Albert G. White III sold 114,992 shares of the business's stock in a transaction dated Thursday, September 19th. The stock was sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the sale, the chief executive officer now owns 165,273 shares in the company, valued at $18,267,624.69. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 256,373 shares of company stock valued at $27,637,427. Company insiders own 2.00% of the company's stock.

Analysts Set New Price Targets

A number of equities analysts have weighed in on COO shares. Piper Sandler increased their price target on shares of Cooper Companies from $115.00 to $120.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Wells Fargo & Company increased their price target on shares of Cooper Companies from $110.00 to $115.00 and gave the stock an "overweight" rating in a research note on Thursday, August 29th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research note on Thursday, August 29th. Robert W. Baird increased their price target on shares of Cooper Companies from $118.00 to $125.00 and gave the stock an "outperform" rating in a research note on Thursday, August 29th. Finally, Stifel Nicolaus reaffirmed a "buy" rating and set a $115.00 price target (up previously from $110.00) on shares of Cooper Companies in a research note on Thursday, August 29th. Three investment analysts have rated the stock with a hold rating and ten have issued a buy rating to the stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and an average target price of $115.00.

Cooper Companies Stock Up 1.4 %

COO stock traded up $1.48 during mid-day trading on Friday, hitting $108.26. 733,653 shares of the company were exchanged, compared to its average volume of 1,105,725. The company has a market capitalization of $21.56 billion, a PE ratio of 63.68, a price-to-earnings-growth ratio of 2.56 and a beta of 0.98. The company has a current ratio of 1.99, a quick ratio of 1.18 and a debt-to-equity ratio of 0.33. The Cooper Companies, Inc. has a twelve month low of $75.93 and a twelve month high of $112.38. The firm has a fifty day simple moving average of $104.28 and a 200 day simple moving average of $96.44.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its quarterly earnings data on Wednesday, August 28th. The medical device company reported $0.96 earnings per share for the quarter, topping the consensus estimate of $0.91 by $0.05. The company had revenue of $1 billion during the quarter, compared to analyst estimates of $997.30 million. Cooper Companies had a net margin of 9.45% and a return on equity of 9.08%. The firm's revenue for the quarter was up 7.8% compared to the same quarter last year. During the same period last year, the business earned $0.84 EPS. On average, research analysts forecast that The Cooper Companies, Inc. will post 3.65 earnings per share for the current fiscal year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.